Arrangement to Provide Additional Product Supply to Aurora, Growth Acceleration for WeedMD Vancouver, BC and Toronto, ON – June 28, 2017 – Aurora Cannabis Inc. (the “Company” or “Aurora”) (TSX-V: ACB) (OTCQX: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and WeedMD Inc. (“WeedMD”) (TSX-V: WMD) are pleased to...
Toronto, Canada, June 19, 2017 – WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally licensed producer of medical cannabis, is pleased to announce that on June 16, 2017, the Company received a supplemental license from Health Canada for the production of medical cannabis oils. The...
WHAT IS STROKE? A stroke occurs when blood stops flowing to any part of the brain, thereby damaging brain cells. The effects of a stroke depend on the area of the brain that was damaged and the extent of the damage done. The brain is the control...
Toronto, Canada, June 15, 2017 - WeedMD Inc. (TSX VENTURE: WMD) ("WeedMD" or the "Company"), is pleased to announce that it has entered into a Letter of Intent with Tokyo Smoke BrandCo to license Van der Pop, North America's female-focused cannabis brand. The partnership will...
Toronto, Canada, June 13, 2017 -- WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”), a federally licensed producer of medical cannabis, is pleased to announce that it will begin selling cannabis clones to patients registered for home grow under the Access to Cannabis for Medical Purposes...
On May 24, 2017, WeedMD's CFO, Keith Merker, took part in a Reddit AMA. Below is a brief transcript of this event. Question: I have a couple questions for you: A close friend of mine is a family physician in Ontario. He says he currently will not...
Toronto, Canada, May 31, 2017 – WeedMD Inc. (TSX-V:WMD) (“WeedMD” or the “Company”) is pleased to announce it has officially begun registering patients and fulfilling orders through its online store. The WeedMD team has passionately worked towards this goal for the past three years, and...
Cited from the New England Journal of Medicine: 2017; 376:2011-2020 May 25, 2017: In this double-blind, placebo-controlled trial, we randomly assigned 120 children and young adults with the Dravet syndrome and drug-resistant seizures to receive either cannabidiol oral solution at a dose of 20 mg per kilogram...
AYLMER - A final federal hurdle cleared, and an impressive IPO to boot, are putting budding medicinal marijuana manufacturer WeedMD on the map. The start-up made its debut on the Toronto Stock Exchange Thursday and received its final Health Canada clearance to sell its product the...
TORONTO, May 01, 2017 (GLOBE NEWSWIRE) -- WeedMD Inc. (WMD.V) (“WeedMD” or the “Company”) is pleased to announce that it received an amendment to its license from Health Canada to include the sale of dried cannabis products and starting materials to patients on April 28,...
